Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ribba

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Clinical Pharmacology and Therapeutics|July 25, 2014
The use of model-based tumor-size metrics to predict survivalB Ribba, N Holford, F Mentré
CPT: Pharmacometrics & Systems Pharmacology|January 20, 2016
Preclinical Modeling of Tumor Growth and Angiogenesis Inhibition to Describe Pazopanib Clinical Effects in Renal Cell CarcinomaA Ouerdani, H Struemper, A B Suttle, et al.
Bulletin of Mathematical Biology|February 5, 2005
A mathematical model of Doxorubicin treatment efficacy for non-Hodgkin's lymphoma: investigation of the current protocol through theoretical modelling resultsB Ribba, K Marron, Z Agur, et al.
Journal of Theoretical Biology|August 26, 2006
A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agentsB Ribba, O Saut, T Colin, et al.
IET Systems Biology|May 20, 2009
Chemotherapy may be delivered based on an integrated view of tumour dynamicsB Ribba, B You, M Tod, et al.
Computational and Mathematical Methods in Medicine|October 11, 2012
Time-course analysis of main markers of primary infection in cats with the feline immunodeficiency virusB Ribba, H El Garch, S Brunet, et al.
Oncogene|December 7, 2010
Combining epitope-distinct antibodies to HER2: cooperative inhibitory effects on invasive growthA Emde, C-R Pradeep, D A Ferraro, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 9, 2014
A review of mixed-effects models of tumor growth and effects of anticancer drug treatment used in population analysisB Ribba, N H Holford, P Magni, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 19, 2016
Modeling Longitudinal Preclinical Tumor Size Data to Identify Transient Dynamics in Tumor Response to Antiangiogenic DrugsL G Hutchinson, H-J Mueller, E A Gaffney, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 7, 2017
Methodologies for Quantitative Systems Pharmacology (QSP) Models: Design and EstimationB Ribba, H P Grimm, B Agoram, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|July 25, 2014
The use of model-based tumor-size metrics to predict survivalB Ribba, N Holford, F Mentré
CPT: Pharmacometrics & Systems Pharmacology|January 20, 2016
Preclinical Modeling of Tumor Growth and Angiogenesis Inhibition to Describe Pazopanib Clinical Effects in Renal Cell CarcinomaA Ouerdani, H Struemper, A B Suttle, et al.
Bulletin of Mathematical Biology|February 5, 2005
A mathematical model of Doxorubicin treatment efficacy for non-Hodgkin's lymphoma: investigation of the current protocol through theoretical modelling resultsB Ribba, K Marron, Z Agur, et al.
Journal of Theoretical Biology|August 26, 2006
A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agentsB Ribba, O Saut, T Colin, et al.
IET Systems Biology|May 20, 2009
Chemotherapy may be delivered based on an integrated view of tumour dynamicsB Ribba, B You, M Tod, et al.
Computational and Mathematical Methods in Medicine|October 11, 2012
Time-course analysis of main markers of primary infection in cats with the feline immunodeficiency virusB Ribba, H El Garch, S Brunet, et al.
Oncogene|December 7, 2010
Combining epitope-distinct antibodies to HER2: cooperative inhibitory effects on invasive growthA Emde, C-R Pradeep, D A Ferraro, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 9, 2014
A review of mixed-effects models of tumor growth and effects of anticancer drug treatment used in population analysisB Ribba, N H Holford, P Magni, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 19, 2016
Modeling Longitudinal Preclinical Tumor Size Data to Identify Transient Dynamics in Tumor Response to Antiangiogenic DrugsL G Hutchinson, H-J Mueller, E A Gaffney, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 7, 2017
Methodologies for Quantitative Systems Pharmacology (QSP) Models: Design and EstimationB Ribba, H P Grimm, B Agoram, et al.
Pageof 2